Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats

Sho Ichi Yamagishi, Takanori Matsui, Kazuo Nakamura, Takafumi Yoshida, Masayoshi Takeuchi, Hiroyoshi Inoue, Yumiko Yoshida, Tsutomu Imaizumi

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The interaction of advanced glycation end products (AGEs) and their receptor (RAGE) elicits inflammatory and proliferative responses in retinal vascular wall cells, thereby being involved in the pathogenesis of diabetic retinopathy. Recently, pigment-epithelium-derived factor (PEDF) has also been shown to play a role in diabetic retinopathy. However, the effects of PEDF on RAGE gene expression remain to be elucidated. Therefore, we investigated here whether PEDF could prevent diabetes- or AGE-induced RAGE gene expression and the way that it might achieve this effect. Administration of PEDF or pyridoxal phosphate, an AGE inhibitor, suppressed RAGE gene expression in the eye of streptozotocin-induced diabetic rats. Further, intravenous injection of AGEs to normal rats increased RAGE gene expression, which was also blocked by PEDF. In vitro, PEDF or an antioxidant N-acetylcysteine blocked the AGE-induced RAGE gene induction in microvascular endothelial cells. In addition, PEDF completely inhibited superoxide generation and NF-κB activation in AGE-exposed endothelial cells. These results demonstrated that PEDF could inhibit diabetes- or AGE-induced RAGE gene expression by blocking the superoxide-mediated NF-κB activation. Our present study suggests that pharmacological upregulation or substitution of PEDF may play a protective role against diabetic retinopathy by attenuating the deleterious effect of AGEs.

Original languageEnglish
Pages (from-to)92-97
Number of pages6
JournalOphthalmic Research
Volume39
Issue number2
DOIs
Publication statusPublished - 2007 Mar
Externally publishedYes

Fingerprint

Gene Expression
Diabetic Retinopathy
Superoxides
Endothelial Cells
Advanced Glycosylation End Product-Specific Receptor
pigment epithelium-derived factor
Retinal Vessels
Advanced Glycosylation End Products
Pyridoxal Phosphate
Acetylcysteine
Streptozocin
Intravenous Injections
Cell Wall
Up-Regulation
Antioxidants
Pharmacology
Genes

Keywords

  • Advanced glycation end products
  • Diabetic retinopathy
  • Oxidative stress
  • Pigment-epithelium-derived factor
  • Receptor for advanced glycation end products

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. / Yamagishi, Sho Ichi; Matsui, Takanori; Nakamura, Kazuo; Yoshida, Takafumi; Takeuchi, Masayoshi; Inoue, Hiroyoshi; Yoshida, Yumiko; Imaizumi, Tsutomu.

In: Ophthalmic Research, Vol. 39, No. 2, 03.2007, p. 92-97.

Research output: Contribution to journalArticle

Yamagishi, Sho Ichi ; Matsui, Takanori ; Nakamura, Kazuo ; Yoshida, Takafumi ; Takeuchi, Masayoshi ; Inoue, Hiroyoshi ; Yoshida, Yumiko ; Imaizumi, Tsutomu. / Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. In: Ophthalmic Research. 2007 ; Vol. 39, No. 2. pp. 92-97.
@article{f946ae72e0bb4833bbf4619fcb969860,
title = "Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats",
abstract = "The interaction of advanced glycation end products (AGEs) and their receptor (RAGE) elicits inflammatory and proliferative responses in retinal vascular wall cells, thereby being involved in the pathogenesis of diabetic retinopathy. Recently, pigment-epithelium-derived factor (PEDF) has also been shown to play a role in diabetic retinopathy. However, the effects of PEDF on RAGE gene expression remain to be elucidated. Therefore, we investigated here whether PEDF could prevent diabetes- or AGE-induced RAGE gene expression and the way that it might achieve this effect. Administration of PEDF or pyridoxal phosphate, an AGE inhibitor, suppressed RAGE gene expression in the eye of streptozotocin-induced diabetic rats. Further, intravenous injection of AGEs to normal rats increased RAGE gene expression, which was also blocked by PEDF. In vitro, PEDF or an antioxidant N-acetylcysteine blocked the AGE-induced RAGE gene induction in microvascular endothelial cells. In addition, PEDF completely inhibited superoxide generation and NF-κB activation in AGE-exposed endothelial cells. These results demonstrated that PEDF could inhibit diabetes- or AGE-induced RAGE gene expression by blocking the superoxide-mediated NF-κB activation. Our present study suggests that pharmacological upregulation or substitution of PEDF may play a protective role against diabetic retinopathy by attenuating the deleterious effect of AGEs.",
keywords = "Advanced glycation end products, Diabetic retinopathy, Oxidative stress, Pigment-epithelium-derived factor, Receptor for advanced glycation end products",
author = "Yamagishi, {Sho Ichi} and Takanori Matsui and Kazuo Nakamura and Takafumi Yoshida and Masayoshi Takeuchi and Hiroyoshi Inoue and Yumiko Yoshida and Tsutomu Imaizumi",
year = "2007",
month = "3",
doi = "10.1159/000099244",
language = "English",
volume = "39",
pages = "92--97",
journal = "Ophthalmic Research",
issn = "0030-3747",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats

AU - Yamagishi, Sho Ichi

AU - Matsui, Takanori

AU - Nakamura, Kazuo

AU - Yoshida, Takafumi

AU - Takeuchi, Masayoshi

AU - Inoue, Hiroyoshi

AU - Yoshida, Yumiko

AU - Imaizumi, Tsutomu

PY - 2007/3

Y1 - 2007/3

N2 - The interaction of advanced glycation end products (AGEs) and their receptor (RAGE) elicits inflammatory and proliferative responses in retinal vascular wall cells, thereby being involved in the pathogenesis of diabetic retinopathy. Recently, pigment-epithelium-derived factor (PEDF) has also been shown to play a role in diabetic retinopathy. However, the effects of PEDF on RAGE gene expression remain to be elucidated. Therefore, we investigated here whether PEDF could prevent diabetes- or AGE-induced RAGE gene expression and the way that it might achieve this effect. Administration of PEDF or pyridoxal phosphate, an AGE inhibitor, suppressed RAGE gene expression in the eye of streptozotocin-induced diabetic rats. Further, intravenous injection of AGEs to normal rats increased RAGE gene expression, which was also blocked by PEDF. In vitro, PEDF or an antioxidant N-acetylcysteine blocked the AGE-induced RAGE gene induction in microvascular endothelial cells. In addition, PEDF completely inhibited superoxide generation and NF-κB activation in AGE-exposed endothelial cells. These results demonstrated that PEDF could inhibit diabetes- or AGE-induced RAGE gene expression by blocking the superoxide-mediated NF-κB activation. Our present study suggests that pharmacological upregulation or substitution of PEDF may play a protective role against diabetic retinopathy by attenuating the deleterious effect of AGEs.

AB - The interaction of advanced glycation end products (AGEs) and their receptor (RAGE) elicits inflammatory and proliferative responses in retinal vascular wall cells, thereby being involved in the pathogenesis of diabetic retinopathy. Recently, pigment-epithelium-derived factor (PEDF) has also been shown to play a role in diabetic retinopathy. However, the effects of PEDF on RAGE gene expression remain to be elucidated. Therefore, we investigated here whether PEDF could prevent diabetes- or AGE-induced RAGE gene expression and the way that it might achieve this effect. Administration of PEDF or pyridoxal phosphate, an AGE inhibitor, suppressed RAGE gene expression in the eye of streptozotocin-induced diabetic rats. Further, intravenous injection of AGEs to normal rats increased RAGE gene expression, which was also blocked by PEDF. In vitro, PEDF or an antioxidant N-acetylcysteine blocked the AGE-induced RAGE gene induction in microvascular endothelial cells. In addition, PEDF completely inhibited superoxide generation and NF-κB activation in AGE-exposed endothelial cells. These results demonstrated that PEDF could inhibit diabetes- or AGE-induced RAGE gene expression by blocking the superoxide-mediated NF-κB activation. Our present study suggests that pharmacological upregulation or substitution of PEDF may play a protective role against diabetic retinopathy by attenuating the deleterious effect of AGEs.

KW - Advanced glycation end products

KW - Diabetic retinopathy

KW - Oxidative stress

KW - Pigment-epithelium-derived factor

KW - Receptor for advanced glycation end products

UR - http://www.scopus.com/inward/record.url?scp=34248146103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248146103&partnerID=8YFLogxK

U2 - 10.1159/000099244

DO - 10.1159/000099244

M3 - Article

VL - 39

SP - 92

EP - 97

JO - Ophthalmic Research

JF - Ophthalmic Research

SN - 0030-3747

IS - 2

ER -